GO
| HSI1 | 24,641.17 | -132.16 | 191.37B |
| HSCEI1 | 8,856.70 | -26.25 | 62.98B |
| Back Zoom + Zoom - Block Traded | |
|
2025-07-31 08:27:22 Vaccine firm AB&B BIO-TECH-B (02627.HK) is conducting its IPO in Hong Kong. The company proposes to offer 33.4426 million H-shares globally, with the Hong Kong public offering accounting for 10% (around 3.3444 million shares) and the international offering accounting for 90% (30.0982 million shares). The offer price ranges from HKD12.9 to HKD15.5 per share, aiming to raise up to around HKD518 million. The entry fee for a board lot of 200 shares is around HKD3,131.26. The IPO will commence today (31st) and close next Tuesday (August 5), with the listing of shares expected on August 8. CITIC Securities and CMBI are acting as the company's joint sponsors. ~ AAStocks Financial News Web Site: www.aastocks.com | |